US Map / South Dakota
State SD

Clinical Trials in South Dakota

Recruiting clinical trials with at least one study location in South Dakota. Data updated daily from ClinicalTrials.gov.

Total Trials
43
Recruiting Now
43
← Back to US Map
Top Conditions in South Dakota
Heart Failure (2)Lung Non-Small Cell Carcinoma (2)Stage II Lung Cancer AJCC v8 (2)Stage IIIA Lung Cancer AJCC v8 (2)Stage IIIB Lung Cancer AJCC v8 (2)Anatomic Stage IV Breast Cancer AJCC v8 (2)Breast Cancer (2)Stage IV Nasopharyngeal Carcinoma AJCC v8 (2)Anatomic Stage I Breast Cancer AJCC v8 (1)Anatomic Stage II Breast Cancer AJCC v8 (1)Anatomic Stage IIIA Breast Cancer AJCC v8 (1)Anatomic Stage IIIB Breast Cancer AJCC v8 (1)

Frequently Asked Questions — Clinical Trials in South Dakota

How many clinical trials are currently recruiting in South Dakota?
ClinicalMetric currently tracks 43 actively recruiting clinical trials with at least one location in South Dakota. The total number of registered studies—including active but not currently enrolling trials—is 43. Trial availability is updated daily from ClinicalTrials.gov, and new studies open enrollment regularly throughout the year.
What types of clinical trials are available in South Dakota?
South Dakota hosts clinical trials across a broad range of medical conditions, including Heart Failure, Lung Non-Small Cell Carcinoma, Stage II Lung Cancer AJCC v8, and many others. Trials range from Phase 1 early-safety studies to Phase 4 post-approval surveillance, as well as observational and behavioral research. Academic medical centers, community hospitals, and specialized research clinics throughout South Dakota serve as trial sites for studies sponsored by NIH, pharmaceutical companies, and independent investigators.
How do I join a clinical trial near me in South Dakota?
To join a clinical trial in South Dakota, browse the recruiting studies listed on this page, review the eligibility criteria for each trial, and contact the study site directly. Your primary care physician or specialist can also refer you to clinical trials relevant to your diagnosis. Many academic medical centers in South Dakota maintain dedicated clinical trials offices that can match you with appropriate studies based on your medical profile and diagnosis.

Recruiting Trials in South Dakota

NCT01524276 N/A
Recruiting
Product Surveillance Registry
Condition
Cardiac Rhythm Disorders
Enrollment
100,000 pts
Location
United States, Argentina, Australia
Sponsor
Medtronic
View Trial →
NCT06393374 Phase 3
Recruiting
Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did ...
Condition
Triple-Negative Breast Cancer
Enrollment
1,530 pts
Location
United States, Argentina, Australia
Sponsor
Merck Sharp & Dohme LLC
View Trial →
NCT07284849 Phase 3
Recruiting
A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and...
Condition
CRC (Colorectal Cancer)
Enrollment
700 pts
Location
United States, Argentina, Australia
Sponsor
Incyte Corporation
View Trial →
NCT04267848 Phase 3
Recruiting
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemoth...
Condition
Lung Non-Small Cell Carcinoma
Enrollment
1,210 pts
Location
United States, Guam
Sponsor
National Cancer Institute (NCI
View Trial →
NCT05946213 Phase 3
Recruiting
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in...
Condition
Prostate Adenocarcinoma
Enrollment
1,209 pts
Location
United States, Canada, Hong Kong
Sponsor
NRG Oncology
View Trial →
NCT05382338 Phase 3
Recruiting
A Study of Treatment for Medulloblastoma Using Sodium Thiosulfate to Reduce Hear...
Condition
Childhood Medulloblastoma
Enrollment
225 pts
Location
United States, Canada
Sponsor
Children's Oncology Group
View Trial →
NCT04566328 Phase 3
Recruiting
Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Mu...
Condition
Plasma Cell Myeloma
Enrollment
1,450 pts
Location
United States, Puerto Rico
Sponsor
ECOG-ACRIN Cancer Research Gro
View Trial →
NCT07064473 Phase 3
Recruiting
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empag...
Condition
Diabetes Mellitus, Type 2
Enrollment
11,800 pts
Location
United States, Argentina, Australia
Sponsor
Boehringer Ingelheim
View Trial →
NCT07144761 N/A
Recruiting
Evaluating Patient Reported Outcomes and Surgeon Satisfaction With Ziplyft™
Condition
Blepharoplasty
Enrollment
200 pts
Location
United States
Sponsor
Osheru Inc.
View Trial →
NCT06395103 Phase 1, Phase 2
Recruiting
Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants Wit...
Condition
B-cell Acute Lymphoblastic Leukemia
Enrollment
90 pts
Location
United States, Australia, Belgium
Sponsor
Merck Sharp & Dohme LLC
View Trial →
NCT07227597 Phase 1, Phase 2
Recruiting
A Clinical Study of Gocatamig (MK-6070) and Infinatamab Deruxtecan (MK-2400) in ...
Condition
Small Cell Lung Cancer Extensive Stage
Enrollment
170 pts
Location
United States, Chile, China
Sponsor
Merck Sharp & Dohme LLC
View Trial →
NCT06064097 Phase 2
Recruiting
A Study Using Nivolumab, in Combination With Chemotherapy Drugs to Treat Nasopha...
Condition
Stage II Nasopharyngeal Carcinoma AJCC v8
Enrollment
50 pts
Location
United States, Canada, New Zealand
Sponsor
National Cancer Institute (NCI
View Trial →
NCT03488693 Phase 3
Recruiting
Regional Radiotherapy in Biomarker Low-Risk Node Positive and T3N0 Breast Cancer
Condition
Breast Cancer
Enrollment
2,140 pts
Location
United States, Canada
Sponsor
Canadian Cancer Trials Group
View Trial →
NCT05904080 Phase 2
Recruiting
Testing Nivolumab and Ipilimumab Immunotherapy With or Without the Targeted Drug...
Condition
Metastatic Nasopharyngeal Carcinoma
Enrollment
50 pts
Location
United States
Sponsor
National Cancer Institute (NCI
View Trial →
NCT07252739 Phase 2
Recruiting
KEYMAKER-U01 Substudy 01J: A Study of Pembrolizumab Plus MK-1084 in Participants...
Condition
Malignant Neoplasm
Enrollment
130 pts
Location
United States, China, Finland
Sponsor
Merck Sharp & Dohme LLC
View Trial →
NCT04242095 N/A
Recruiting
Collection of Research Data and Samples From Patients Who Experience Immunothera...
Condition
Malignancy
Enrollment
240 pts
Location
United States
Sponsor
Alliance for Clinical Trials i
View Trial →
NCT07214779 Phase 3
Recruiting
Study to Evaluate INCB123667 Versus Investigator's Choice of Chemotherapy in Par...
Condition
Ovarian Cancer
Enrollment
466 pts
Location
United States, Australia, Belgium
Sponsor
Incyte Corporation
View Trial →
NCT06203600 Phase 2, Phase 3
Recruiting
Adding Nivolumab to Usual Treatment for People With Advanced Stomach or Esophage...
Condition
Advanced Esophageal Adenocarcinoma
Enrollment
224 pts
Location
United States
Sponsor
National Cancer Institute (NCI
View Trial →
Page 2 of 2 — 43 trials total
← Prev
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology